Frontiers Health, 2024 took place in Berlin on 17 and 18 October and brought together a global community of 800 healthcare change-makers, including patients, company founders, senior executives, senior government officials, academic researchers, investors and healthcare professionals with the common goal of promoting health for all through innovation.
During the conference, featuring different formats and thematic tracks over 200 speakers came together to discuss and share experiences, contributing to the collective effort to drive the future of healthcare. With over 60 sessions and 100 of the most promising start-ups and scaleups in the industry, participants found inspiration and opportunities to engage at various stages, exploring potential partnerships during networking sessions. Frontiers Health Berlin returns in 2025 on 11 and 12 November, but first the Italian edition is scheduled to take place in Milan on 3 December 2024.
Frontier Health Italia enjoys the patronage of Assolombarda, Farmindustria and Cluster Lombardo Scienze della Vita, and organised by Eversana, takes place at the Assolombarda Congress Centre.
Frontiers Health Italia 2024 aims to offer participants a comprehensive overview of the latest trends and innovations through a rich programme of speeches and interactive sessions. Among the main topics: global scenarios and trends emerged from the recent international conference Frontiers Health 2024; integration of health innovation policies at European and international level; digital medical devices and digital therapies (DTx); development of digital health at territorial level; digitally enhanced care pathways; innovations in insurance and welfare; change management and competences in process innovation.
Also taking place during the day, of which Startupbusiness is media partner, are the demo day of VITA Accelerator, an event dedicated to Italian and international start-ups, realised in collaboration with CDP Venture Capital and Eversana, and a deep dive on artificial intelligence that explores the potential of AI in the commercialisation and innovation of life sciences, curated by Eversana.
ALL RIGHTS RESERVED ©